VERACYTE, INC. Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities
VERACYTE, INC. (VCYT) reported Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities of $50.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities · last filed 2026-07-31
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2025-12-31 was $51.20M.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2025-09-30 was $51.05M.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2024-12-31 was $0.00.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2024-09-30 was $0.00.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2025 was $153.31M.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2023 was $5.00M, a 60.57% decline from fiscal 2022.
- VERACYTE, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2022 was $12.68M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 3 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 6 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 9 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.94M 10-Q · filed 2026-07-31 | |||
| 2025-12-31 | $51.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $102.25M derived: sum of 2 quarters · filed 2026-02-26 | $153.31M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $51.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $102.12M 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $51.06M 10-Q · filed 2026-07-31 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $5.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $5.00M 10-Q · filed 2024-11-07 | $4.99M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.00M 10-Q · filed 2024-08-07 | $4.99M derived: sum of 3 quarters · filed 2025-02-28 | $15.51M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-08 | $4.99M derived: sum of 2 quarters · filed 2025-02-28 | $15.51M derived: sum of 3 quarters · filed 2025-02-28 | $17.68M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.51M derived: sum of 2 quarters · filed 2025-02-28 | $12.68M derived: sum of 3 quarters · filed 2025-02-28 | $12.68M 10-K · filed 2025-02-28 |
| 2022-09-30 | $10.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $12.70M derived: sum of 2 quarters · filed 2023-11-08 | $12.70M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.17M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-05 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |